NEW YORK (360Dx) – Running point-of-care testing at the bedside of a home-bound patient is an ultimate distal site in a healthcare network, but to date the uptake of diagnostics in the home healthcare space has been limited.

A four-year-old startup, iAssay, hopes to change that by providing healthcare workers a single instrument that can run many different commercial tests. The company plans on partnering with commercial test makers to add assays to its universal assay reader.